116 related articles for article (PubMed ID: 10535222)
1. [Heroin-assisted treatment of opiate addicts--former and current research emphasis].
Steffen T; Kaufmann B; Blättler R; Dobler-Mikola A; Gutzwiller F; Uchtenhagen A
Gesundheitswesen; 1999; 61(8-9):407-12. PubMed ID: 10535222
[TBL] [Abstract][Full Text] [Related]
2. [Co-morbidity: psychiatric disorder of opiate addicts at entry into heroin-assisted treatment].
Frei A; Rehm J;
Psychiatr Prax; 2002 Jul; 29(5):251-7. PubMed ID: 12101491
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic factors from a long-term follow-up of heroin-assisted treatment in Switzerland 1994-2007].
Frick U; Wiedermann W; Schaub M; Uchtenhagen A; Rehm J
Psychiatr Prax; 2010 May; 37(4):175-82. PubMed ID: 20148381
[TBL] [Abstract][Full Text] [Related]
4. Mortality in heroin-assisted treatment in Switzerland 1994-2000.
Rehm J; Frick U; Hartwig C; Gutzwiller F; Gschwend P; Uchtenhagen A
Drug Alcohol Depend; 2005 Aug; 79(2):137-43. PubMed ID: 16002023
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic prescription of heroin to drug addicts].
Cancrini L
Recenti Prog Med; 2001 Jan; 92(1):1-5. PubMed ID: 11260964
[TBL] [Abstract][Full Text] [Related]
6. Controlled trial of prescribed heroin in the treatment of opioid addiction.
March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
[TBL] [Abstract][Full Text] [Related]
7. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
[TBL] [Abstract][Full Text] [Related]
8. [Influence of psychiatric disorders in the effectiveness of a long-term methadone maintenance treatment].
Fernández Miranda J; González García-Portilla M; Sáiz Martínez P; Gutiérrez Cienfuegos E; Bobes García J
Actas Esp Psiquiatr; 2001; 29(4):228-32. PubMed ID: 11470057
[TBL] [Abstract][Full Text] [Related]
9. Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study.
Rehm J; Gschwend P; Steffen T; Gutzwiller F; Dobler-Mikola A; Uchtenhagen A
Lancet; 2001 Oct; 358(9291):1417-23. PubMed ID: 11705488
[TBL] [Abstract][Full Text] [Related]
10. [Diversified prescription of narcotics to heroin addicts. Basis, design, research plan].
Uchtenhagen A
Schweiz Rundsch Med Prax; 1994 Aug; 83(34):931-6. PubMed ID: 7939045
[TBL] [Abstract][Full Text] [Related]
11. From illegal poison to legal medicine: a qualitative research in a heroin-prescription trial in Spain.
Romo N; Poo M; Ballesta R;
Drug Alcohol Rev; 2009 Mar; 28(2):186-95. PubMed ID: 19320704
[TBL] [Abstract][Full Text] [Related]
12. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
Goeb JL; Coste J; Bigot T; Ferrand I
Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
[TBL] [Abstract][Full Text] [Related]
13. Development of pharmaceutical heroin preparations for medical co-prescription to opioid dependent patients.
Klous MG; Van den Brink W; Van Ree JM; Beijnen JH
Drug Alcohol Depend; 2005 Dec; 80(3):283-95. PubMed ID: 15916865
[TBL] [Abstract][Full Text] [Related]
14. [Economic evaluation of the Swiss project on medically prescribed heroin substitution treatment].
Frei A
Psychiatr Prax; 2001 Jul; 28 Suppl 1():S41-4. PubMed ID: 11533906
[No Abstract] [Full Text] [Related]
15. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of treatment-resistant heroin addicts with and without DSM-IV axis I psychiatric comorbidity (dual diagnosis).
Maremmani I; Pacini M; Lubrano S; Perugi G; Tagliamonte A; Pani PP; Gerra G; Shinderman M
Eur Addict Res; 2008; 14(3):134-42. PubMed ID: 18552489
[TBL] [Abstract][Full Text] [Related]
17. Comparison between heroin and heroin-cocaine polyabusers: a psychopathological study.
Bandettini Di Poggio A; Fornai F; Paparelli A; Pacini M; Perugi G; Maremmani I
Ann N Y Acad Sci; 2006 Aug; 1074():438-45. PubMed ID: 17105942
[TBL] [Abstract][Full Text] [Related]
18. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
[TBL] [Abstract][Full Text] [Related]
19. Depression in methadone maintenance treatment patients: rate and risk factors.
Peles E; Schreiber S; Naumovsky Y; Adelson M
J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
[TBL] [Abstract][Full Text] [Related]
20. [Drug substitution treatment of heroin dependent patients with codeine preparations--treatment effects from the viewpoint of the physicians and patients].
Krausz M; Degkwitz P; Wernecke A; Verthein U; Chorzelski G; Behrendt K
Psychiatr Prax; 1995 Sep; 22(5):179-85. PubMed ID: 7480367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
